Table 1.
Clinical characteristics of the patients
| Patients (n = 35) | |
|---|---|
| Age ± SD, years (range) | 43.6 ± 11.3 |
| Female, n (%) | 20 (57%) |
| Mean ± SD initial weight, kg | 93.2 ± 16 |
| Mean ± SD initial BMI, kg/m2 | 34 ± 4.9 |
| Class I (≥27.5–32.4 kg/m2) | 15 (43%) |
| Class II (32.5–37.4 kg/m2) | 13 (37%) |
| Class III (≥37.5 kg/m2) | 7 (20%) |
| Ethnicity, n (%) | |
| Chinese | 18 (51%) |
| Indian | 11 (31%) |
| Malay | 4 (12%) |
| Others | 2 (6%) |
| Comorbid illness, n (%) | |
| Hypertension | 17 (49%) |
| Fatty liver | 14 (40%) |
| Diabetes mellitus | 8 (23%) |
| Coronary artery disease | 7 (20%) |
| Liver cirrhosis | 3 (8.6%) |
| Antiplatelets use, n (%) | 6 (17%) |
| Aspirin | 3 (50%) |
| Clopidogrel | 2 (33%) |
| Both | 1 (17%) |
| Completed 6 months, n (%) | 10 (29%) |
| Completed 3 months, n (%) | 21 (60%) |
| Completed 1 month, n (%) | 33 (94%) |
| Follow‐up loss, n (%) | 4 (11%) |